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ABSTRACT
Objectives We performed a cross- sectional analysis 
of data from the nationwide Korea National Health and 
Nutrition Examination Survey to evaluate the association 
between obesity and chronic rhinosinusitis with nasal 
polyps (CRSwNP) or without nasal polyp (CRSsNP).
Design Retrospective cross- sectional analysis of health 
survey data.
Setting Voluntary survey of representative South Korean 
populations.
Participants In total, 32 384 individuals aged 19 years 
or older with available data on CRS and obesity were 
included.
Primary and secondary outcome measures Diagnosis 
of CRSwNP or CRSsNP was performed by trained 
otolaryngologists through sinus endoscopy and surveys 
of medical history. General and central obesity was 
diagnosed using body mass index (BMI) and waist 
circumference (WC), respectively.
Methods A multivariate logistic regression analysis 
was used to clarify the association between CRSwNP or 
CRSsNP and obesity according to BMI and WC. Non- obese 
individuals were recruited as controls.
Results The prevalence of CRSwNP was higher in the 
general (OR, 1.438; 95% CI, 1.170 to 1.768; p<0.001) 
and central (OR, 1.251; 95% CI, 1.031 to 1.520; p=0.033) 
obesity groups than in the control group. Prevalence of 
CRSsNP was not correlated with obesity. In a logistic 
regression analysis, olfactory dysfunction (OR, 1.329; 95% 
CI, 1.137 to 1.553; p<0.001) and purulent discharge (OR, 
1.383; 95% CI, 1.193 to 1.603; p<0.001) showed a higher 
incidence in the central obesity group than in the control 
group.
Conclusions We demonstrated an association between 
CRSwNP and general and central obesity. Further 
investigations on the mechanism underlying this 
correlation are necessary for an improved understanding 
of the pathogenesis of CRSwNP.
INTRODUCTION
Obesity is a rapidly increasing global health 
problem. Over 1.9 billion people are classified 
as overweight and over 650 million are cate-
gorised as obese, globally.1 Diseases related 
to obesity include asthma, cardiovascular 
diseases and diabetes mellitus. Certain types 
of cancers are also associated with obesity due 
to chronic inflammation.2 3 There have been 
reports suggesting that obesity can potentially 
result in chronic inflammatory diseases.4 
However, controversies remain about the 
effect of obesity in sinonasal inflammatory 
diseases.5 6
Chronic rhinosinusitis (CRS) is defined 
as persistent inflammation of the sinonasal 
mucosa due to multifactorial causes.7 Staph-
ylococcus aureus or Alternaria fungi have been 
reported as critical agents for CRS,8 and anti-
body deficiencies in primary immunodefi-
ciencies may predispose certain patients to 
recurrent sinus infections.9
CRS is categorised as CRS with nasal polyps 
(CRSwNP) and CRS without nasal polyps 
(CRSsNP) based on the sinus endoscopy.10 
CRSwNP is typically characterised as a type 2 
inflammatory response, exhibiting enhanced 
tissue eosinophilia and higher levels of 
eosinophilic granule protein,11 12 eosinophil 
chemotactic proteins, interleukin (IL)-5 and 
Strengths and limitations of this study
 ► This study used data from the Korea National Health 
and Nutrition Examination Survey, a representative 
national population- based study in Korea.
 ► The study sample included a large number of par-
ticipants (N=32 384) who had a wide age range 
(19–86 years).
 ► This study examined general and central obesity, 
which are important public health concerns.
 ► The association between chronic rhinosinusitis and 
obesity was explored after adjusting for age, sex, di-
agnosis of hypertension and other relevant clinical 
characteristics.
 ► The causal relationship between obesity and chronic 
rhinosinusitis phenotypes was not assessed in this 
study.
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IL-13.13 14 In general, patients with CRSwNP have more 
severe nasal obstruction than patients with CRSsNP, and 
effective medical treatments for patients with CRSwNP 
are limited.15 16 In addition, patients with CRSwNP have a 
significantly lower health- related quality of life compared 
with healthy controls.17
Several studies have reported that obesity is a potential 
chronic inflammatory condition and leads to chronic 
systemic inflammation.4 18 However, to our knowledge, 
no previous studies have reported the association of 
CRSwNP with general and central obesity under the 
influence of various confounding factors in large nation-
wide studies. As a representative measure of obesity, body 
mass index (BMI) is the most widely used parameter for 
general obesity diagnosis and is correlated with various 
chronic diseases and mortality risk. However, a limitation 
of BMI is that it does not represent the body fat distri-
bution.19 Waist circumference (WC) has been commonly 
used as a simple and clinically applicable method to eval-
uate central obesity.20 Thus, using both of these measure-
ments is appropriate when investigating the relationship 
between general and central obesity and CRSwNP. In this 
study, we aimed to investigate this association using data 
retrieved from the Korea National Health and Nutrition 
Examination Survey (KNHANES), with subgroup analysis 
and stratification for major confounding factors.
MATERIALS AND METHODS
Study design and population
The data for the study were collected by the KNHANES 
between 2008 and 2012. The KNHANES was a national 
cross- sectional survey conducted by the Ministry of 
Health and Welfare of South Korea. Specially trained 
medical investigators used well- designed questionnaires 
to evaluate representative South Korean populations. 
The evaluation included physical examination, health- 
related surveys and nutritional status assessment. In the 
current study, 34 670 participants aged ≥19 years were 
included. After excluding 2286 participants with missing 
data on CRS or obesity, the data of 32 384 participants 
were analysed. All eligible participants provided written 
informed consent. The study followed the Ethical Prin-
ciples for Medical Research Involving Human Subjects 
based on the Declaration of Helsinki.
General characteristics
Of the total KNHANES study population, only the partic-
ipants aged ≥19 years were included in this study. Socio- 
demographic and economic variables of the participants 
were acquired with a self- reported questionnaire, which 
collected information on cigarette smoking habits, house-
hold income, alcohol consumption, education level and 
region of residence. Alcohol drinkers were categorised as 
heavy (>30 g/day), mild (1–30 g/day) and non- drinkers. 
Smokers were categorised as non- smokers or ex- smokers 
and current smokers. Education level was categorised 
as graduation from high school (≥13 years) or not. 
Household income was classified into quartiles by the 
number of family members, following recommendations 
of the WHO.
The medical evaluation included assessment of blood 
pressure, height, weight and WC. Hypertension was 
confirmed when the systolic or diastolic blood pressure 
measurements were repeatedly over 140/90 mm Hg. 
Height (cm) was measured using a stadiometer (Seca 
225, Seca, Germany) while the participants had their 
upper back parallel to the wall, were facing forward and 
were without shoes. Weight (kg) was measured by a digital 
medical weighing scale (GL-6000–20, G- Tech Interna-
tional, South Korea) with participants wearing light 
clothes. Results were recorded by trained examiners and 
presented up to the second decimal. The physical exam-
ination devices were replaced with recently calibrated 
devices once a year to maintain the accuracy of results. 
BMI was calculated by dividing the weight (kg) by the 
squared height (m2). WC was measured at the midpoint 
level between the costal margin and the iliac crest at the 
end of a normal expiration. Chronic diseases, such as 
stroke, bronchial asthma, allergic rhinitis, depression and 
pulmonary tuberculosis, previously diagnosed by a physi-
cian were also investigated throughout the survey.
Diagnosis of CRSwNP and CRSsNP
CRS was diagnosed by trained otolaryngologists using 
sinus endoscopy and surveys of medical histories 
following the European Position Paper on Rhinosinusitus 
and Nasal Polyps (EPOS) 2012 guidelines for epidemio-
logical studies.
Each participant was evaluated by a single otolaryngol-
ogist, and overall, approximately 200 trained otolaryngol-
ogists were involved in the KNHANES. CRS was defined 
as inflammation of the nose and paranasal sinuses with 
the presence of two or more of the following symptoms 
for over 12 weeks: (1) nasal blockage/congestion/
obstruction; (2) sinonasal discharge; (3) facial pressure/
pain; and (4) reduction or loss of smell.21 An objective 
diagnosis of either CRSsNP or CRSwNP was made using 
sinus endoscopy. The participants’ socio- demographics, 
general health characteristics and comorbidities were 
compared with determine the risk factors for CRS.
Definition of general obesity according to the BMI
The WHO Regional Office for the Western Pacific Region 
has announced the following BMI standards: normal, 
18.5–22.9 kg/m2; overweight, 23–24.9 kg/m2; and obese 
≥25 kg/m2.22 This definition for obesity was followed by 
the Korean Society for the Study of Obesity and was used 
in the present study to define general obesity.23
Definition of central obesity according to the WC
The Korean Society for the Study of Obesity recommends 
that the WC cut- off level for diagnosing central obesity 
be 90 cm for men and 85 cm for women aged ≥19 years. 
These cut- off values were defined by receiver operating 
characteristics curve analysis, based on the representative 
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sample data acquired during the KNHANES in 1998.24 
The same standards were applied in this study to define 
central obesity in the participants.
Statistical analysis
All statistical analyses were conducted with the SAS soft-
ware, V.9.4. Differences with p values below 0.05 were 
considered statistically significant. SAS/STAT survey anal-
yses were conducted because the KNHANES had applied 
a stratified cluster sampling method when selecting 
participants from 2008 to 2012. Descriptive statistics have 
been presented as means (SEs) for categorical variables 
and weighted percentages (SEs) for continuous variables 
and frequencies. A Pearson’s χ2 test was used to compare 
categorical variables, and an independent samples t- test 
was used to compare continuous variables. The SAS 
PROC SURVEYREG was used to analyse continuous vari-
ables, and the PROC SURVEYFREQ was used for categor-
ical variables. A multiple logistic regression analysis was 
conducted by the SAS PROC SURVEYLOGISTIC, after 
adjusting for multiple variables, to clarify the association 
between CRS phenotypes and general and central obesity 
(BMI- related and WC- related, respectively). Models were 
run after adding age and sex for model 1; smoking and 
severe drinking for model 2; and family income, resi-
dence, hypertension, stroke, bronchial asthma, influenza 
vaccination, allergic rhinitis, and pulmonary tuberculosis 
for model 3.
Patient and public involvement
The study population was not involved in the develop-
ment of the research questionnaires, in the analysis or in 
drawing conclusions from the results.
RESULTS
Demographics of the study participants
Among the total participants, 32 384 were categorised 
as normal, overweight or obese, according to BMI. The 
demographic and clinical characteristics of these partic-
ipants are presented in table 1. The mean age was 42.65 
(0.23) years for participants with normal weight, 47.29 
(0.24) years for overweight and 47.05 (0.22) years for 
obese participants. Factors with significant differences 
among the groups were age, sex, smoking status, severe 
drinking, family income, residence, hypertension, depres-
sion, bronchial asthma, influenza vaccination, allergic 
rhinitis and stroke. Using the WC standard, 23 260 partici-
pants were considered normal and 8690 participants were 
diagnosed with central obesity. Table 2 shows the clinical 
characteristics of the participants according to the pres-
ence of WC- based central obesity.
Prevalence of CRS in relation to general and central obesity
The overall prevalence of CRS in the participants 
categorised by BMI was 5.81 (0.31)% in the normal 
weight group, 5.91 (0.37)% in the overweight group 
and 6.70 (0.36)% in the obese group. The normal and 
obese groups differed significantly when assessed by 
regression analysis (OR, 1.164; 95% CI, 1.009 to 1.342; 
p=0.036). The prevalence of CRSwNP in the normal 
and obese groups was 2.20 (0.16)% and 3.43 (0.25)%, 
respectively; while that of CRSsNP was 3.36 (0.21)% and 
3.50 (0.29)%, respectively.
Among the groups categorised by WC, the overall 
prevalence of CRS was 5.89 (0.24)% in the normal 
group and 6.81 (0.39)% in the centrally obese group. 
The prevalence of CRSwNP was 3.44 (0.26%) in the 












Age 42.65 (0.23) 47.29 (0.24) 47.05 (0.22) <0.001
Sex (female) 9235 57.87 (0.53) 4054 45.15 (0.64) 5520 44.16 (0.55) <0.001
Severe drinking 2761 20.67 (0.46) 1707 25.51 (0.65) 2316 26.87 (0.57) <0.001
Current smoking 2936 24.64 (0.48) 1600 26.92 (0.70) 2204 28.61 (0.58) <0.001
Residence (rural area) 3307 18.15 (1.18) 1771 18.86 (1.27) 2519 20.57 (1.37) <0.001
Family income (intermediate/
high)
8665 58.48 (0.75) 4658 59.99 (0.82) 5930 56.67 (0.79) 0.003
Allergic rhinitis 1198 16.43 (0.61) 501 13.17 (0.71) 670 13.44 (0.62) <0.001
Hypertension 1979 10.03 (0.31) 1748 17.50 (0.48) 3249 25.38 (0.54) <0.001
Stroke 227 1.09 (0.09) 165 1.40 (0.12) 249 1.62 (0.12) 0.006
Bronchial asthma 410 2.63 (0.16) 251 2.91 (0.25) 388 3.34 (0.20) 0.027
Influenza vaccination 9123 70.98 (0.56) 4566 68.33 (0.69) 6117 68.01 (0.61) <0.001
Depression 543 3.42 (0.19) 299 3.45 (0.23) 452 3.85 (0.23) 0.271
Pulmonary tuberculosis 904 5.66 (0.23) 368 4.49 (0.28) 360 3.12 (0.19) <0.001
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centrally obese group and 2.40 (0.14)% in the normal 
group. The prevalence of CRSsNP was 3.66 (0.21)% 
in the centrally obese group and 3.61 (0.32)% in the 
normal group (figure 1).
Correlation between CRSwNP prevalence and general and 
central obesity
Among the groups classified by the BMI, CRSwNP was 
more prevalent in the general obesity group than in 
the normal group (OR, 1.582; 95% CI, 1.294 to 1.934; 
p<0.001), but did not differ between the normal and 
overweight groups (OR, 1.120; 95% CI, 0.894 to 1.404; 
p=0.324). Multivariate regression analysis was performed 
under various confounding factors with models 1, 2 
and 3, showing a higher prevalence of CRSwNP in the 
general obesity group than in the normal group (OR, 
1.438; 95% CI, 1.170 to 1.768; p<0.001 in model 3). 
When participants were classified by the WC, univariate 
logistic regression analysis showed that the prevalence 
of CRSwNP in the central obesity group was higher than 
in the normal group (OR, 1.447; 95% CI, 1.208 to 1.733; 
p<0.001). Multivariate regression analysis using the 
three models resulted in a similar outcome (OR, 1.251; 
95% CI, 1.031 to 1.502; p=0.023 in model 3) (table 3).
Correlation between CRSsNP prevalence and general and 
central obesity
The correlation between CRSsNP and obesity was inves-
tigated. We found no difference in CRSsNP prevalence 
between the overweight and normal groups (OR, 1.019; 
95% CI, 0.864 to 1.203; p=0.820), but a significant differ-
ence was noted between general obesity and normal 
groups (OR, 1.164; 95% CI, 1.009 to 1.342; p=0.036). 
Multivariate regression analysis with models 1, 2 and 3 
found no difference in CRSsNP prevalence between the 
normal and overweight (OR, 0.986; 95% CI, 0.832 to 
1.169; p=0.872 in model 3) or in the normal and obese 
(OR, 1.130; 95% CI, 0.975 to 1.310; p=0.104 in model 





n Weighted % (SE) n Weighted % (SE)
Age 43.17 (0.21) 50.37 (0.29) <0.001
Sex (female) 11 315 51.02 (0.39) 4124 49.04 (0.68) 0.023
Severe drinking 4167 23.19 (0.41) 1563 25.99 (0.65) <0.001
Current smoking 4318 26.81 (0.44) 1419 26.85 (0.68) 0.956
Residence (rural area) 4418 17.74 (1.29) 1989 23.33 (1.71) <0.001
Family income (intermediate/high) 11 754 58.92 (0.71) 4086 57.61 (0.91) 0.154
Allergic rhinitis 1890 15.62 (0.49) 486 11.86 (0.64) <0.001
Hypertension 3832 12.10 (0.28) 3183 30.73 (0.65) <0.001
Stroke 386 1.10 (0.07) 262 2.06 (0.15) <0.001
Bronchial asthma 672 2.62 (0.13) 388 3.95 (0.25) <0.001
Depression 866 26.13 (0.97) 429 30.40 (1.66) 0.023
Pulmonary tuberculosis 1288 4.87 (0.17) 351 3.66 (0.22) <0.001
Figure 1 Prevalence of CRSwNP or CRSsNP according to the presence of obesity. (A) Prevalence of CRSwNP or CRSsNP 
according to general obesity. (B) Prevalence of CRSwNP or CRSsNP according to central obesity. BMI, body mass index; CRS, 
chronic rhinosinusitis; CRSsNP, CRS without nasal polyps; CRSwNP, CRS with nasal polyps; WC, waist circumference. *p<0.05, 
**p<0.01 (univariate logistic regression analysis).
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3) groups. When grouped by WC, the prevalence of 
CRSsNP in the central obesity group was higher than 
in the normal group on univariate analysis (OR, 1.168; 
95% CI, 1.020 to 1.338; p=0.024 in model 3) but not 
in the multivariate regression analysis using the three 
models (OR, 1.144; 95% CI, 0.993 to 1.318; p=0.063 in 
model 3) (table 4).
Association of sinonasal symptoms with general and central 
obesity
In the logistic regression analysis, olfactory dysfunction 
(OR, 1.329; 95% CI, 1.137 to 1.553; p<0.001) and puru-
lent discharge on sinus endoscopy (OR, 1.383; 95% CI, 
1.193 to 1.603; p<0.001) showed a higher incidence rate 
in the central obesity group than in the normal group. 
Table 3 Association between CRSwNP and obesity according to BMI and WC
Model Variable OR (95% CI) P value
Unadjusted Overweight vs normal 1.120 (0.894 to 1.404) 0.324
Obesity vs normal 1.582 (1.294 to 1.934) 0.000*
Model 1† Overweight vs normal 0.959 (0.765 to 1.204) 0.378
Obesity vs normal 1.382 (1.129 to 1.693) 0.002*
Model 2‡ Overweight vs normal 0.944 (0.731 to 1.220) 0.660
Obesity vs normal 1.465 (1.179 to 1.821) <0.001*
Model 3§ Overweight vs normal 0.968 (0.762 to 1.228) 0.787
Obesity vs normal 1.438 (1.170 to 1.768) <0.001*
Unadjusted Central obesity vs normal 1.447 (1.208 to 1.733) <0.001*
Model 1† Central obesity vs normal 1.226 (1.016 to 1.480) 0.033*
Model 2‡ Central obesity vs normal 1.257 (1.021 to 1.547) 0.030*
Model 3§ Central obesity vs normal 1.251 (1.031 to 1.520) 0.023*
*Differences with p<0.05 were considered statistically significant.
†Model 1: adjusted for age and sex.
‡Model 2: adjusted for age, sex, current smoking and severe drinking.
§Model 3: adjusted for age, sex, current smoking, severe drinking, family income, residence, hypertension, stroke, bronchial asthma, influenza 
vaccination, allergic rhinitis and pulmonary tuberculosis.
BMI, body mass index; CRSwNP, chronic rhinosinusitis with nasal polyps; WC, waist circumference.
Table 4 Association between CRSsNP and obesity according to BMI and WC
Model Variable OR (95% CI) P value
Unadjusted Overweight vs normal 1.019 (0.864 to 1.203) 0.820
Obesity vs normal 1.164 (1.009 to 1.342) 0.036*
Model 1† Overweight vs normal 0.956 (0.810 to 1.129) 0.598
Obesity vs normal 1.091 (0.944 to 1.262) 0.237
Model 2‡ Overweight vs normal 0.960 (0.811 to 1.136) 0.634
Obesity vs normal 1.110 (0.960 to 1.285) 0.159
Model 3§ Overweight vs normal 0.986 (0.832 to 1.169) 0.872
Obesity vs normal 1.130 (0.975 to 1.310) 0.104
Unadjusted Central obesity vs normal 1.168 (1.020 to 1.338) 0.024*
Model 1† Central obesity vs normal 1.124 (0.980 to 1.291) 0.095
Model 2‡ Central obesity vs normal 1.137 (0.989 to 1.306) 0.071
Model 3§ Central obesity vs normal 1.144 (0.993 to 1.318) 0.063
*Differences with p<0.05 were considered statistically significant.
†Model 1: adjusted for age and sex.
‡Model 2: adjusted for age, sex, current smoking and severe drinking.
§Model 3: adjusted for age, sex, current smoking, severe drinking, family income, residence, hypertension, stroke, bronchial asthma, influenza 
vaccination, allergic rhinitis and pulmonary tuberculosis.
BMI, body mass index; CRSsNP, chronic rhinosinusitis without nasal polyp; WC, waist circumference.
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Daily life disability (OR, 1.454; 95% CI, 1.083 to 1.952; 
p=0.012) was more prevalent in the general obesity group 
than in the normal group. Pale nasal mucosa on sinus 
endoscopy was more prevalent in the normal group than 
in the central (OR, 0.870; 95% CI, 0.760 to 0.996; p=0.043) 
and general (OR, 0.746; 95% CI, 0.591 to 0.942; p=0.013) 
obesity groups. The presence of rhinorrhoea/postnasal 
drip and nasal obstruction did not differ between the 
normal and obesity groups (table 5).
DISCUSSION
In the present study, the prevalence of CRSwNP was 
significantly higher in the BMI- based general obesity 
and WC- based central obesity groups compared with the 
normal group. The association between CRSsNP and 
either general or central obesity was not significant. In 
addition, common sinonasal symptoms seen in CRS such 
as purulent discharge and olfactory dysfunction were 
more frequent in the central obesity group.
Previous studies investigating the association between 
obesity and sinus infections have shown inconsistent 
results. Obesity was reported to not affect the severity of 
sinonasal diseases in patients with asthma.5 While child-
hood obesity was associated with the occurrence of acute 
otitis media, an association between obesity and allergic 
rhinitis or CRS was not observed.6 Other studies have 
shown that a high BMI was associated with the prevalence 
of CRS.25 26 However, these studies did not classify the 
prevalence of CRS based on the presence of nasal polyps; 
therefore, the effect of adiposity on CRSwNP has not 
been determined.
In this study, the association between general obesity 
and CRSsNP was insignificant in contrast to that with 
CRSwNP, after adjusting for various confounding factors. 
This result reveals that factors related to general obesity 
might be closely related to the polypogenesis process in 
sinonasal inflammatory disease, the mechanism for which 
has not been fully identified yet. Inflammatory pathophys-
iological processes are associated with obesity and certain 
respiratory diseases.27 Several mechanisms involved in the 
contribution of obesity to asthma progression have been 
studied. The increased production of cytokines, adipocy-
tokines, adiponectin and other mediators by the adipose 
tissue is considered to have important implications in 
immune responses.28 29 There are reports indicating 
that increased levels of inflammatory mediators30 and 
metabolic hormones31 could be the possible causes for 
immune system dysfunction in obese patients. Therefore, 
the significant association between CRSwNP and obesity 
found in this study could be explained by nasal polyps 
being strongly related to recurrent and severe CRS in 
most cases,30 which is possibly due to decreased immune 
function seen in obesity.
The association between central obesity and CRSwNP 
was significant after adjusting for various confounding 
factors, in contrast to CRSsNP, in this study. This differ-
ence suggests that mechanisms related to central obesity 
might impact the pathogenesis of nasal polyps in CRS. 
The prevalence of central obesity, defined as excessive 
fat accumulation around the abdomen, is increasing and 
is associated with elevated mortality risk.32 Visceral fat 
is correlated with elevated production of inflammatory 
factors, leading to increased metabolic complications.33 
Studies have reported that the connection between 
obesity and inflammatory diseases is mediated by oxida-
tive stress and inflammation.32 Compared with other 
fat deposits, visceral fat has more pronounced inflam-
matory effects, including increased levels of free fatty 
acids, adipocytokines and inflammatory molecules, all 
playing critical roles in inflammatory diseases.34 Super-
fluous adiposity in the upper trunk has been reported 
to be a risk factor for dyslipidaemia, type 2 diabetes, 
Table 5 Sinonasal symptoms according to presence of general and central obesity
Symptoms Variable OR (95% CI) P value
Rhinorrhoea/PND General obesity vs normal 0.736 (0.511 to 1.058) 0.097
Central obesity vs normal 0.917 (0.763 to 1.101) 0.349
Nasal obstruction General obesity vs normal 1.302 (0.927 to 1.828) 0.126
Central obesity vs normal 1.097 (0.928 to 1.297) 0.276
Olfactory dysfunction General obesity vs normal 1.011 (0.722 to 1.416) 0.948
Central obesity vs normal 1.329 (1.137 to 1.553) <0.001*
Daily life disability General obesity vs normal 1.454 (1.083 to 1.952) 0.012*
Central obesity vs normal 1.121 (0.948 to 1.326) 0.179
Pale mucosa General obesity vs normal 0.746 (0.591 to 0.942) 0.013*
Central obesity vs normal 0.870 (0.760 to 0.996) 0.043*
Purulent discharge General obesity vs normal 1.400 (0.987 to 1.988) 0.059
Central obesity vs normal 1.383 (1.193 to 1.603) <0.001*
*Differences with p<0.05 were considered statistically significant.
PND, postnasal drip; WC, waist circumference.
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hypertension, cardiovascular diseases and hyperinsuli-
naemia.35 The metabolic and endocrine effects of obesity, 
and the changes in production of hormones including 
insulin, adipocytokines, insulin- like growth factor-1 and 
insulin- like growth factor binding protein-3 secreted by 
adipose tissue have been reported as potential causes for 
the development of adenomatous polyps and cancer in 
the colon.36 37 The mechanism of polypogenesis in the 
nasal cavity should be further investigated from a meta-
bolic prospective.
We also found that sinonasal symptoms such as olfac-
tory dysfunction and purulent discharge showed a higher 
prevalence in the central obesity group. This suggests that 
central obesity might be associated with an increased risk 
of chronic rhinosinusitis, showing a higher incidence of 
local sinonasal inflammatory signs. Generally, the mucosa 
during allergic inflammation is pale and swollen, while it 
is mostly reddish during acute infections and in overuse 
of topical nasal sprays.38 In our study, pale mucosa, 
which is more prevalent in allergic rhinitis, showed a 
higher prevalence in the normal group, consistent with a 
previous report which showed that obese patients have a 
higher incidence of non- allergic rhinitis.39 Further inves-
tigations on the mechanism behind these observations is 
warranted.
This cross- sectional study is limited by its inability to eval-
uate the causal relationship between obesity and the CRS 
phenotypes. In addition, since the KNHANES is based on 
self- reported questionnaires in reporting parameters on 
confounding factors, response biases may have occurred.
Besides the confounders used in the multiple regres-
sion analysis, psychiatric conditions,40 gastro- oesophageal 
reflux disease,41 autoimmune disease9 and various envi-
ronmental exposures42 are potential risk factors for CRS. 
However, these factors were not included as confounders 
due to unavailability of data. Furthermore, obesity is 
an important risk factor for asthma in adults,43 and the 
possible correlation between severity of asthma and 
obesity could not be considered in this analysis. Neverthe-
less, the present study has notable advantages in that it has 
evaluated the correlation between CRS phenotypes and 
general and central obesity using a well- defined repre-
sentative sample of adults in South Korea. In addition, 
endoscopic examinations and medical interviews were 
conducted by trained otolaryngologists, and confounding 
factors related to the association between CRS and obesity 
were adjusted for in the statistical analysis.
CONCLUSION
This study demonstrated a distinct association between 
CRSwNP and general and central obesity in a large 
nationwide population sample. Among sinonasal symp-
toms, the incidences of olfactory dysfunction and puru-
lent discharge were higher in the central obesity group 
than in the control group. These results suggest a possible 
role of obesity in the development of CRSwNP, which is 
mostly refractory to medical treatment and often recurs 
even after surgery. Further investigations on the mecha-
nism of this correlation is anticipated for elucidating the 
pathogenesis of CRSwNP.
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